Uncertainty on markets can often encourage investors to search for safe ports, especially those with history of solid performance. United (NYSE: UNH) had tended to adapt to the bill, having not tabled a miss of results since 2008.
Until last week, when, in the words of the CEO Andrew Witty, the health company experienced an “unusual and unacceptable” miss. The company generated revenues of $ 109.58 billion and a normalized BPA of $ 7.20, which failed respectively the expectations of $ 2.03 billion and – $ 0.09.
The company also lowered its BPA directives in annual year to $ 26.00 to $ 26.50, below the previous beach from $ 29.50 to $ 30.00.
The company cited two main reasons for disappointing figures, an increase in activities within its Medicare Advantage companies and higher reimbursement figures in 2025.
The Miss led to a large sale and to losses of more than 20% last Thursday – the last day of negotiation before the closing of the markets for the Holiday Friday holidays.
A crisis, is going well, is a terrible thing to waste. An investor known by the pseudonym JR Research argues that this applies to the recent sales experienced by Unitedhealth.
“Investors who are waiting for their time to buy the action should not miss the incredible opportunity offered by this … noStive,” says the 5 -star investor.
JR recalls that UNH is a massive company, with many operating routes, including technology and analysis and care based on value. The investor also explains that the company benefits from the profitability of the sector, comparing favorably to competition.
“It has a well -diverse commercial model centered on its health insurance scale and its massive leadership,” adds Jr. “I think that confers the company by unmatched resilience among its peers of health.”
In addition, extreme drop has given the UNH evaluations much cheaper. Its multiple term remuneration price of 15.4x is much lower than its average of 10 years, and JR notes that, in the past, these types of declines have previously led investors to UNH.
“His multiple evaluation has also been appropriately corrected, going to levels that have previously attracted investors to buy the decreases,” conclude JR Research, who assesses a purchase. (To look at the history of JR Research, click here)
Wall Street is also in love with UNH. With 21 purchase notes, UNH has a strong purchase consensus note. Its average price of 12 months of $ 635.17 has an increase of ~ 40% of the coming year. (See Stock Unh forecast))
To find good ideas for the actions of a merchant to attractive assessments, visit the best actions of Tipranks to buy, a tool that unites all the information on Tipranks actions.
Warning: The opinions expressed in this article are only those of the star investor. Content is intended to be used for information only. It is very important to do your own analysis before investing.
Warning and disclosure
